Cargando…
Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort
Aim of the study was to evaluate possible associations between cognitive dysfunctions and development of Levodopa Induced Dyskinesia (LID). PD patients from the Parkinson’s disease Cognitive impairment Study cohort who underwent a baseline and follow-up neuropsychological evaluations were enrolled....
Autores principales: | Luca, Antonina, Monastero, Roberto, Baschi, Roberta, Cicero, Calogero Edoardo, Mostile, Giovanni, Davì, Marco, Restivo, Vincenzo, Zappia, Mario, Nicoletti, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806828/ https://www.ncbi.nlm.nih.gov/pubmed/33441571 http://dx.doi.org/10.1038/s41598-020-79110-7 |
Ejemplares similares
-
Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study
por: Nicoletti, Alessandra, et al.
Publicado: (2020) -
Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study
por: Luca, Antonina, et al.
Publicado: (2022) -
Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019) -
Influence of Drugs on Mild Cognitive Impairment in Parkinson’s Disease: Evidence from the PACOS Study
por: Cicero, Calogero Edoardo, et al.
Publicado: (2022) -
Side effects induced by the acute levodopa challenge in Parkinson’s Disease and atypical parkinsonisms
por: Vasta, Rosario, et al.
Publicado: (2017)